Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 30,058
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12599639 | Joint function-improving composition | 🖼🧊📄§ | 2026-04-14 | 2042-01-07 | 0 | 31 |
| 12600955 | Replication-competent recombinant herpes simplex virus type 1 (HSV-1) comprising deletions in the ICP6 and IR regions | 🖼🧊📄§ | 2026-04-14 | 2039-08-09 | 0 | 31 |
| 12600740 | Fluorinated N-acetyl glucosamine analogs and xylose derivatives | 🖼🧊📄§ | 2026-04-14 | 2042-06-17 | 0 | 31 |
| 12600973 | CpG ODN having immunoregulatory function and use thereof | 🖼🧊📄§ | 2026-04-14 | 2041-03-31 | 0 | 31 |
| 12600779 | LAG-3-binding molecules and methods of use thereof | 🖼🧊📄§ | 2026-04-14 | 2043-11-21 | 0 | 31 |
| 12600766 | Anti-TDP-43 binding molecules and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2040-05-22 | 0 | 31 |
| 12600724 | Indole alkaloid and preparation method and use thereof | 🖼🧊📄§ | 2026-04-14 | 2042-11-09 | 0 | 31 |
| 12600731 | Isoxazolo[5,4-H]quinazoline compounds as protein kinase inhibitors | 🖼🧊📄§ | 2026-04-14 | 2040-09-03 | 0 | 31 |
| 12600783 | Anti-New York esophageal squamous cell carcinoma 1 (NY-ESO-1) antigen-binding proteins and methods of use thereof | 🖼🧊📄§ | 2026-04-14 | 2040-07-02 | 0 | 31 |
| 12599638 | Feed and composition comprising lactic acid bacteria and fatty acid | 🖼🧊📄§ | 2026-04-14 | 2041-09-21 | 0 | 31 |
| 12600760 | Chimeric antigen receptors targeting CD79B and CD19 | 🖼🧊📄§ | 2026-04-14 | 2039-12-13 | 0 | 31 |
| 12600968 | Methods and compositions for reprogramming cells | 🖼🧊📄§ | 2026-04-14 | 2042-07-20 | 0 | 31 |
| 12600796 | Constructs for chimeric antigen receptors | 🖼🧊📄§ | 2026-04-14 | 2041-09-16 | 0 | 31 |
| 12600782 | Anti-PD-L1 and PD-L2 antibody and derivatives and use thereof | 🖼🧊📄§ | 2026-04-14 | 2041-03-30 | 0 | 31 |
| 12600711 | Triazacyclododecansulfonamide (TCD)-based protein secretion inhibitors | 🖼🧊📄§ | 2026-04-14 | 2042-05-11 | 0 | 31 |
| 12600778 | Rage antibodies, fragments and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2040-11-02 | 0 | 31 |
| 12600767 | Compounds and methods targeting epiregulin | 🖼🧊📄§ | 2026-04-14 | 2042-05-19 | 0 | 31 |
| 12600959 | PH20 polypeptide variants, formulations and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2045-03-05 | 0 | 31 |
| 12600733 | KRAS inhibitors | 🖼🧊📄§ | 2026-04-14 | 2045-09-30 | 0 | 31 |
| 12600750 | Methods for inactivating and storing respiratory syncytial virus | 🖼🧊📄§ | 2026-04-14 | 2039-07-08 | 0 | 31 |
| 12599635 | Compositions and treatments for ischemic injuries | 🖼🧊📄§ | 2026-04-14 | 2041-03-22 | 0 | 31 |
| 12600725 | Selective GRP94 inhibitors and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2042-01-21 | 0 | 31 |
| 12600729 | New-type benzazepine fused ring derivative | 🖼🧊📄§ | 2026-04-14 | 2042-03-04 | 0 | 31 |
| 12599602 | Methods for treating cholestasis | 🖼🧊📄§ | 2026-04-14 | 2044-01-25 | 0 | 31 |
| 12600771 | Antibody for binding to interleukin 4 receptor | 🖼🧊📄§ | 2026-04-14 | 2043-11-15 | 0 | 31 |
| 12599658 | Hepatitis B virus-specific T cell responses | 🖼🧊📄§ | 2026-04-14 | 2040-06-05 | 0 | 31 |
| 12599571 | Method for preparing polydopamine nanomotor using urease, and use of same | 🖼🧊📄§ | 2026-04-14 | 2040-03-10 | 0 | 31 |
| 12599617 | Methods of treating head and neck cancers with hemp extract | 🖼🧊📄§ | 2026-04-14 | 2042-10-26 | 0 | 31 |
| 12599603 | Methods of treatment | 🖼🧊📄§ | 2026-04-14 | 2040-09-03 | 0 | 31 |
| 12599606 | Therapies with 3rd generation EGFR tyrosine kinase inhibitors | 🖼🧊📄§ | 2026-04-14 | 2043-08-22 | 0 | 31 |
| 12599579 | Compositions and compounds containing ketone bodies and/or ketone body precursors and one or more amino acids | 🖼🧊📄§ | 2026-04-14 | 2045-07-07 | 0 | 31 |
| 12599601 | Antifungal composition containing carbazole compound as active ingredient | 🖼🧊📄§ | 2026-04-14 | 2040-10-16 | 0 | 31 |
| 12600715 | Soluble guanylate cyclate activators for treating systemic sclerosis | 🖼🧊📄§ | 2026-04-14 | 2043-11-02 | 0 | 31 |
| 12600755 | Cobra 1/NELF-B as a booster for efficacy of CD8+ T cell-based therapy | 🖼🧊📄§ | 2026-04-14 | 2041-02-25 | 0 | 31 |
| 12600716 | Compounds for modulating activity of FXR and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2040-10-12 | 0 | 31 |
| 12599600 | Compositions and methods for preventing and treating headache through enhancing 2-arachydonyl glyerol activity | 🖼🧊📄§ | 2026-04-14 | 2041-05-26 | 0 | 31 |
| 12599661 | Immunogenic compositions of hepatitis c virus and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2042-12-12 | 0 | 31 |
| 12599634 | Nerve guidance conduit comprising neural crest stem-like cells and/or Schwann cell precursor-like cells and methods of making and using the same | 🖼🧊📄§ | 2026-04-14 | 2042-09-22 | 0 | 31 |
| 12600964 | Compound for treatment of heart failure | 🖼🧊📄§ | 2026-04-14 | 2041-11-17 | 0 | 31 |
| 12600794 | 5T4 binding polypeptides and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2045-07-21 | 0 | 31 |
| 12599662 | Methods and compositions for treating cancers | 🖼🧊📄§ | 2026-04-14 | 2039-08-06 | 0 | 31 |
| 12600717 | Tricyclic compounds as inhibitors of KRAS | 🖼🧊📄§ | 2026-04-14 | 2042-07-13 | 0 | 31 |
| 12600797 | Fibrin-binding antibody and pharmaceutical composition containing antibody | 🖼🧊📄§ | 2026-04-14 | 2041-03-30 | 0 | 31 |
| 12599604 | Application of JAK inhibitor in kidney disease | 🖼🧊📄§ | 2026-04-14 | 2041-12-10 | 0 | 31 |
| 12600772 | Therapeutic agent for asthma containing IL-6 inhibitor | 🖼🧊📄§ | 2026-04-14 | 2039-01-31 | 0 | 31 |
| 12600765 | Target for anti-cancer and immune-enhancing | 🖼🧊📄§ | 2026-04-14 | 2041-04-09 | 0 | 31 |
| 12600781 | Tumor-targeted agonistic CD28 antigen binding molecules | 🖼🧊📄§ | 2026-04-14 | 2042-11-17 | 0 | 31 |
| 12600785 | Method of screening for compounds that inhibit proliferation of pancreatic cancer cells having a loss-of-function mutation in the RNF43 gene | 🖼🧊📄§ | 2026-04-14 | 2041-02-15 | 0 | 31 |
| 12600784 | Anti-Clec12A antibodies and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2042-04-25 | 0 | 31 |
| 12600787 | Methods for the treatment of thyroid eye disease | 🖼🧊📄§ | 2026-04-14 | 2042-03-10 | 0 | 31 |